Judge Blocks Vaccine Changes; RFK Jr. Revamps CDC Panel Rules
Health Secretary Robert F. Kennedy Jr. is undertaking significant changes to the membership rules of the Advisory Committee on Immunization Practices (ACIP). This action follows a recent judicial ruling deeming most of his prior selections unqualified.
Judge’s Ruling on Vaccine Panel Selections
A March 16 decision by U.S. District Judge Brian Murphy determined that Kennedy’s reconstitution of ACIP was unlawful. The committee is critical as it advises the Centers for Disease Control and Prevention (CDC) on vaccine utilization. Judge Murphy criticized Kennedy for replacing all 17 independent experts on the panel with individuals who share his controversial views on vaccines.
Legal and Regulatory Framework
In his ruling, Judge Murphy stated that Kennedy’s choices violated the Federal Advisory Committee Act. He emphasized that panel members must possess valid expertise in vaccine-related research and practices. Only six out of the 15 members appointed by Kennedy had notable experience in the field.
Revamped ACIP Charter
In response to the ruling, the Department of Health and Human Services (HHS) under Kennedy published a new charter for ACIP on Monday. This revised document expands the criteria for member qualifications.
Changes in Membership Qualifications
The prior charter, established in December, specified that members should have expertise in immunization practices and related fields. The renewed charter now incorporates broader expertise, including:
- Biostatistics
- Toxicology
- Vaccine efficacy and safety
Former ACIP members pointed out that the new criteria appear to relax prior standards, potentially allowing less qualified individuals onto the panel.
Responses and Implications
HHS spokesperson Andrew Nixon characterized the charter renewal as a routine update and dismissed claims of a broader policy shift. This comes after a letter from attorney Aaron Siri, representing a vaccine critical group, urged Kennedy to clarify the committee’s membership criteria.
Future Legal Considerations
Despite the ruling, the Trump administration has not yet filed an appeal, but has a 60-day window to do so. The unfolding situation continues to draw attention and scrutiny regarding vaccine policy reform in the U.S.
